Advertisement
Canada markets close in 2 hours 53 minutes

  • S&P/TSX

    21,859.73
    -13.99 (-0.06%)
     

  • S&P 500

    5,035.13
    -36.50 (-0.72%)
     

  • DOW

    38,009.52
    -451.40 (-1.17%)
     

  • CAD/USD

    0.7313
    +0.0015 (+0.21%)
     

  • CRUDE OIL

    82.54
    -0.27 (-0.33%)
     

  • Bitcoin CAD

    88,319.38
    -313.74 (-0.35%)
     

  • CMC Crypto 200

    1,390.93
    +8.35 (+0.60%)
     

  • GOLD FUTURES

    2,341.80
    +3.40 (+0.15%)
     

  • RUSSELL 2000

    1,972.66
    -22.76 (-1.14%)
     

  • 10-Yr Bond

    4.6940
    +0.0420 (+0.90%)
     

  • NASDAQ

    15,552.73
    -160.02 (-1.02%)
     

  • VOLATILITY

    16.46
    +0.49 (+3.07%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6809
    -0.0010 (-0.15%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, DOWNBEAT GDP

Caterpillar sinks 7% after earnings, management sees weakness in Europe, Asia-Pacific

Exxon tries to break losing streak; Juno & Celgene drug deal; Apollo flunks

Susannah Lee

Time for your daily dose of trending tickers, the stocks you're following based on your Yahoo Finance ticker searches.

Apollo Education 

Investors dropped out of Apollo Education (APOL). Earnings for its third quarter fell 27% as enrollment declined. Apollo schools, which include the University of Phoenix has seen increasing pressure as 'for-profit-education' companies face stricter government regulation.

Exxon Mobil 

A rise in oil prices is gave Exxon Mobil (XOM) a boost straight out of the open. Shares of the world's largest energy company attempted to break a 7-day losing streak. Exxon Mobil retreated as oil declined on the uncertainty in Greece.

ADVERTISEMENT

Get the Latest Market Data and News with the Yahoo Finance App

Juno Therapeutics 

Deal making gave shares of Juno Therapeutics (JUNO) a boost. The drug maker is getting $1 billion from Celgene (CELG). The two are teaming up, in a 10-year-deal, to make autoimmune therapies and cancer treatments.